Ethosomes and Transfersomes: Principles, Perspectives and Practices.

BACKGROUND The success story of liposomes in the treatment of systemic infectious diseases and various carcinomas lead the scientists to the innovation of elastic vesicles to achieve similar success through transdermal route. In this direction, ethosomes and transfersomes were developed with the objective to design the vesicles that could pass through the skin. However, there is a lack of systematic review outlining the principles, method of preparation, latest advancement and applications of ethosomes and transfersomes. This review covers various aspects that would be helpful to scientists in understanding advantages of these vesicular systems and designing a unique nano vesicular delivery system. METHODS Structured search of bibliographic databases for previously published peer-reviewed research papers was explored and data was culminated in terms of principle of these vesicular delivery systems, composition, mechanism of actions, preparation techniques, methods for their characterization and their application. RESULTS A total of 182 papers including both, research and review articles, were included in this review in order to make the article comprehensive and readily understandable. The mechanism of action and composition of ethosomes and transfersomes was extensively discussed. Various methods of preparation such as, rotary film evaporation method, reverse phase evaporation method, vortex/ sonication method, ethanol injection method, freeze thaw methods, along with their advantages has been discussed. It was also discussed that both these elastic nanocarriers offer unique advantages of ferrying the drug across membranes, sustaining drug release as well as protecting the encapsulated bio actives from external environment. The enhanced bioavailability and skin penetration of ethosomes as compared to conventional vesicular delivery systems is attributed to the presence of ethanol in the bilayers while that for transfersomes accrues due to their elasticity along with their ability to retain their shape because of the presence of edge activators. Successful delivery of synthetic drugs as well as phytomedicines has been extensively reported through these vesicles. CONCLUSION Though these vesicular systems offer a good potential for rational drug delivery, a thoughtfully designed process is required to optimize the process variables involved. Industrial scale production of efficacious, safe, cost effective and stable formulations of both these delivery systems appears to be a pre-requisite to ensure their utility as the trans-dermal vehicles.

[1]  Dinesh Mishra,et al.  Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  A. Attama,et al.  Sustained Release and Permeation of Timolol from Surface-Modified Solid Lipid Nanoparticles through Bioengineered Human Cornea , 2009, Current eye research.

[3]  O. Abdallah,et al.  Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. , 2006, International journal of pharmaceutics.

[4]  Ijeoma F. Uchegbu,et al.  Non-ionic surfactant based vesicles (niosomes) in drug delivery , 1998 .

[5]  N. Weiner,et al.  Liposomes as a topical drug delivery system , 1990 .

[6]  Y. Tsai,et al.  Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. , 2008, International journal of pharmaceutics.

[7]  Massimo Fresta,et al.  Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[8]  S. Jose,et al.  Transferosomes - A vesicular transdermal delivery system for enhanced drug permeation , 2011, Journal of advanced pharmaceutical technology & research.

[9]  Goyani Manish,et al.  Transferosomes: A Novel Approach for Transdermal Drug Delivery , 2009 .

[10]  B. Godin,et al.  Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[11]  G. E. El Maghraby,et al.  Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. , 2000, International journal of pharmaceutics.

[12]  G. Awad,et al.  Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. , 2010, International journal of pharmaceutics.

[13]  F. Hu,et al.  Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. , 2009, International journal of pharmaceutics.

[14]  G. Shazly,et al.  Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model. , 2014, Colloids and surfaces. B, Biointerfaces.

[15]  K. Kanamura,et al.  Noninvasive and persistent transfollicular drug delivery system using a combination of liposomes and iontophoresis. , 2011, International journal of pharmaceutics.

[16]  B. W. Barry,et al.  Drug delivery routes in skin: a novel approach. , 2002, Advanced drug delivery reviews.

[17]  Gregor Cevc,et al.  Non-invasive, epicutaneous immunisation with toxoid in deformable vesicles protects mice against tetanus, chiefly owing to a Th2 response. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[18]  Guiling Li,et al.  Preparation and In Vitro Evaluation of Tacrolimus-Loaded Ethosomes , 2012, TheScientificWorldJournal.

[19]  M. Rother,et al.  Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial , 2007, Annals of the rheumatic diseases.

[20]  Guoliang Huang,et al.  Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo , 2011, International journal of nanomedicine.

[21]  Yongtai Zhang,et al.  Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy. , 2014, International journal of pharmaceutics.

[22]  Yuefeng Rao,et al.  Penetration profile and human cadaver skin distribution of finasteride from vesicular nanocarriers , 2015, Drug delivery.

[23]  J A Bouwstra,et al.  Skin structure and mode of action of vesicles. , 2002, Advanced drug delivery reviews.

[24]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[25]  R. Cortesi,et al.  Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. , 2004, Journal of cosmetic science.

[26]  Neeraj Kumar,et al.  Development of Novel Elastic Vesicle-Based Topical Formulation of Cetirizine Dihydrochloride for Treatment of Atopic Dermatitis , 2013, AAPS PharmSciTech.

[27]  J. Breul,et al.  Transcutaneous IL-2 uptake mediated by Transfersomes depends on concentration and fractionated application. , 2004, Cytokine.

[28]  Puneet Utreja,et al.  Elastic Liposomal Formulation for Sustained Delivery of Colchicine: In Vitro Characterization and In Vivo Evaluation of Anti-gout Activity , 2009, The AAPS Journal.

[29]  D. D. de Araújo,et al.  Transdermal delivery of butamben using elastic and conventional liposomes , 2013, Journal of liposome research.

[30]  N. K. Jain,et al.  Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: Development, characterization, and performance evaluation , 2005, AAPS PharmSciTech.

[31]  M. D. da Costa,et al.  A 31P-NMR study on multilamellar liposomes formed from the lipids of a thermophilic bacterium. , 1987, Biochemical and biophysical research communications.

[32]  Meghana S. Kamble,et al.  A study on ethosomes as mode for transdermal delivery of an antidiabetic drug , 2013, Drug delivery.

[33]  M. Foldvari,et al.  Topical dosage form of liposomal tetracaine: Effect of additives on the in vitro release and in vivo efficacy , 1993 .

[34]  G. Cevc Lipid vesicles and other colloids as drug carriers on the skin. , 2004, Advanced drug delivery reviews.

[35]  S. Patil,et al.  Ethosome: A Versatile Tool for Novel Drug Delivery System , 2014 .

[36]  R. Gendle,et al.  Development and Characterization of Curcumin Loaded Tranfersome for Tansdermal Delivery , 2009 .

[37]  N. Weiner,et al.  The influence of particle size of liposomes on the deposition of drug into skin , 1994 .

[38]  G. Biggio,et al.  Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[39]  A. R. Kulkarni,et al.  Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[40]  Yuefeng Rao,et al.  In Vitro Percutaneous Permeation and Skin Accumulation of Finasteride Using Vesicular Ethosomal Carriers , 2008, AAPS PharmSciTech.

[41]  P. Mura,et al.  Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib , 2012, Drug delivery.

[42]  Jianxin Li,et al.  Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes , 2013, International journal of nanomedicine.

[43]  S. Hua Lipid-based nano-delivery systems for skin delivery of drugs and bioactives , 2015, Front. Pharmacol..

[44]  K. Srinivasan,et al.  Formulation of ternary complexes of glyburide with hydroxypropyl-β-cyclodextrin and other solubilizing agents and their effect on release behavior of glyburide in aqueous and buffered media at different agitation speeds , 2012, Drug development and industrial pharmacy.

[45]  A. Ahad,et al.  Nano vesicular lipid carriers of angiotensin II receptor blocker: Anti-hypertensive and skin toxicity study in focus , 2015, Artificial cells, nanomedicine, and biotechnology.

[46]  Hatem Fessi,et al.  Preparation, Characterization and Applications of Liposomes: State of the Art , 2012 .

[47]  A. Hussain,et al.  Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation , 2016, Drug delivery.

[48]  G. Cevc,et al.  Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes. , 2003, Biochimica et biophysica acta.

[49]  C. Demetzos Differential Scanning Calorimetry (DSC): A Tool to Study the Thermal Behavior of Lipid Bilayers and Liposomal Stability , 2008, Journal of liposome research.

[50]  M. L. González-Rodríguez,et al.  New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics. , 2010, International journal of pharmaceutics.

[51]  R. New,et al.  Liposomes : a practical approach , 1990 .

[52]  G. Cevc,et al.  Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. , 2004, Biochimica et biophysica acta.

[53]  T. McIntosh,et al.  Amiodarone-liposome interaction: a multinuclear NMR and X-ray diffraction study. , 1990, Biochimica et biophysica acta.

[54]  Dandan Han,et al.  An overview of liposome lyophilization and its future potential. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[55]  V. Jain,et al.  Lipid Based Vesicular Drug Delivery Systems , 2014 .

[56]  M. Mezei,et al.  Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form. , 1980, Life sciences.

[57]  F. Szoka,et al.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Peter Timmins,et al.  Pharmaceutical applications of confocal laser scanning microscopy: the physical characterisation of pharmaceutical systems. , 2007, Advanced drug delivery reviews.

[59]  G. Cevc,et al.  Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. , 1998, Vaccine.

[60]  S. Bhushan,et al.  Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[61]  O. Katare,et al.  Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. , 2001, International journal of pharmaceutics.

[62]  J. Manosroi,et al.  Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. , 2008, International journal of pharmaceutics.

[63]  G. E. El Maghraby,et al.  Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. , 2000, International journal of pharmaceutics.

[64]  B. Rane,et al.  TRANSFERSOMES: A SURROGATED CARRIER FOR TRANSDERMAL DRUG DELIVERY SYSTEM , 2011 .

[65]  M. A. Khalil,et al.  Transdermal delivery of vancomycin hydrochloride using combination of nano-ethosomes and iontophoresis: in vitro and in vivo study , 2015, Drug delivery.

[66]  P. Bummer,et al.  Simple Chromatographic Method for Simultaneous Analyses of Phosphatidylcholine, Lysophosphatidylcholine, and Free Fatty Acids , 2010, AAPS PharmSciTech.

[67]  A. Fahr,et al.  Particle size of liposomes influences dermal delivery of substances into skin. , 2003, International journal of pharmaceutics.

[68]  D. Paolino,et al.  Paclitaxel-loaded ethosomes®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[69]  G. Cevc,et al.  Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. , 1992, Anesthesia and analgesia.

[70]  A. Fahr,et al.  Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability. , 2010, International journal of pharmaceutics.

[71]  J. Delattre,et al.  Lyophilization and rehydration of liposomes , 1985 .

[72]  T. Gulik-Krzywicki,et al.  Freeze-fracture transmission electron microscopy , 1997 .

[73]  Chong-K. Kim,et al.  Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[74]  Bhupinder Singh,et al.  Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin , 2011, Journal of drug targeting.

[75]  V. L. Silva,et al.  Nanoencapsulation of quercetin and resveratrol into elastic liposomes. , 2013, Biochimica et biophysica acta.

[76]  B. Evrard,et al.  Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome. , 2009, International journal of pharmaceutics.

[77]  N. Škalko-Basnet,et al.  Characterization of various deformable liposomes with metronidazole , 2013, Drug development and industrial pharmacy.

[78]  Jian Zhang,et al.  Physical and chemical stability of drug nanoparticles. , 2011, Advanced drug delivery reviews.

[79]  Bhupinder Singh,et al.  Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. , 2013, International journal of pharmaceutics.

[80]  G. Redziniak Liposomes et peau : passé, présent, futur , 2003 .

[81]  J. Engblom,et al.  A water gradient can be used to regulate drug transport across skin. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[82]  Jinping Wang,et al.  Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation , 2015, Journal of Materials Science: Materials in Medicine.

[83]  G. Cevc,et al.  Functional characterisation of novel analgesic product based on self-regulating drug carriers. , 2008, International journal of pharmaceutics.

[84]  Shashank Jain,et al.  Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route , 2015, Pharmaceutical development and technology.

[85]  Praveen Kumar,et al.  Formulation of Niosomal Gel for Enhanced Transdermal Lopinavir Delivery and Its Comparative Evaluation with Ethosomal Gel , 2012, AAPS PharmSciTech.

[86]  A. Petelska,et al.  Interfacial tension of bilayer lipid membranes , 2012 .

[87]  Vandana Gupta,et al.  Preparation and Characterization of Ethosomes for Topical delivery of Aceclofenac , 2010, Indian journal of pharmaceutical sciences.

[88]  Yongtai Zhang,et al.  Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. , 2014, International journal of pharmaceutics.

[89]  G. Cevc,et al.  New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. , 2001, Biochimica et biophysica acta.

[90]  A. Misra,et al.  Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. , 2009, Indian journal of experimental biology.

[91]  Yunhua Gao,et al.  Enhanced transdermal delivery of 18β-glycyrrhetic acid via elastic vesicles: in vitro and in vivo evaluation , 2012, Drug development and industrial pharmacy.

[92]  E. Peira,et al.  Deformable liposomes for dermal administration of methotrexate. , 2004, International journal of pharmaceutics.

[93]  Yoshiyuki Hattori,et al.  Ultra-deformable liposomes containing bleomycin: in vitro stability and toxicity on human cutaneous keratinocyte cell lines. , 2005, International journal of pharmaceutics.

[94]  K. D. Vernon-Parry,et al.  Scanning Electron Microscopy , 2012, Current protocols in microbiology.

[95]  A. Fadda,et al.  Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs. , 2013, International journal of pharmaceutics.

[96]  M. Babu Transferosomes: An emerging tool for effective transdermal drug delivery , 2014 .

[97]  A. Attama,et al.  Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus , 2014, Expert opinion on drug delivery.

[98]  G. Zhai,et al.  Ethosomes for skin delivery of ropivacaine: preparation, characterization and ex vivo penetration properties , 2015, Journal of liposome research.

[99]  A. Fahr,et al.  Assessment of fluidity of different invasomes by electron spin resonance and differential scanning calorimetry. , 2011, International journal of pharmaceutics.

[100]  Puneet Utreja,et al.  Evaluation of biosafety and intracellular uptake of Cremophor EL free paclitaxel elastic liposomal formulation , 2012, Drug delivery.

[101]  J. Gu,et al.  A Novel Therapy for Laryngotracheal Stenosis , 2015, The Annals of otology, rhinology, and laryngology.

[102]  H. Korting,et al.  Therapeutic progress with topical liposome drugs for skin disease , 1996 .

[103]  B. Godin,et al.  A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. , 2005, The Journal of antimicrobial chemotherapy.

[104]  Andreas G. Schätzlein,et al.  Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. , 1998, Biochimica et biophysica acta.

[105]  G. Cevc,et al.  Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.

[106]  E. Peira,et al.  Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. , 2002, International journal of pharmaceutics.

[107]  A. Williams,et al.  Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin , 2009, Expert opinion on drug delivery.

[108]  R H Guy,et al.  Visualization of skin penetration using confocal laser scanning microscopy. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[109]  M. Cruz,et al.  Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[110]  E. Bendas,et al.  Enhanced transdermal delivery of salbutamol sulfate via ethosomes , 2007, AAPS PharmSciTech.

[111]  M. Rother,et al.  Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations. , 2008, International journal of pharmaceutics.

[112]  Paul J. Harrison,et al.  Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[113]  S. Singh,et al.  Development and characterization of a lovastatin-loaded self-microemulsifying drug delivery system , 2010, Pharmaceutical development and technology.

[114]  Chong-K. Kim,et al.  In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. , 2004, Biomaterials.

[115]  P. Conaghan,et al.  A Randomized, Double-blind, Phase III Trial in Moderate Osteoarthritis Knee Pain Comparing Topical Ketoprofen Gel with Ketoprofen-free Gel , 2013, The Journal of Rheumatology.

[116]  Shivaprakash,et al.  Ethosomes: A Novel Tool for Transdermal Drug Delivery , 2013 .

[117]  M. Raish,et al.  Enhanced anti-inflammatory activity of carbopol loaded meloxicam nanoethosomes gel. , 2014, International journal of biological macromolecules.

[118]  A. Karlberg,et al.  Ethosome formulations of known contact allergens can increase their sensitizing capacity. , 2010, Acta dermato-venereologica.

[119]  R. Guy,et al.  Controlled drug release from a novel liposomal delivery system. II. Transdermal delivery characteristics , 1990 .

[120]  Chong-K. Kim,et al.  Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. , 2006, Biomaterials.

[121]  F. Levi-Schaffer,et al.  Intracellular delivery mediated by an ethosomal carrier. , 2001, Biomaterials.

[122]  O. Abdallah,et al.  Lipid vesicles for skin delivery of drugs: reviewing three decades of research. , 2007, International journal of pharmaceutics.

[123]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[124]  P. Lundahl,et al.  Chromatographic approaches to liposomes, proteoliposomes and biomembrane vesicles. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[125]  A. Ascenso,et al.  Lycopene from tomatoes: vesicular nanocarrier formulations for dermal delivery. , 2013, Journal of agricultural and food chemistry.

[126]  A. Fadda,et al.  Niosomes as carriers for tretinoin. I. Preparation and properties. , 2002, International journal of pharmaceutics.

[127]  Bharti Sapra,et al.  Formulation and evaluation of ethosomes for transdermal delivery of lamivudine , 2007, AAPS PharmSciTech.

[128]  J. Ring,et al.  Improved risk–benefit ratio for topical triamcinolone acetonide in Transfersome® in comparison with equipotent cream and ointment: a randomized controlled trial , 2003, The British journal of dermatology.

[129]  R. Cortesi,et al.  Colloidal Dispersions for the Delivery of Acyclovir: A Comparative Study , 2011, Indian journal of pharmaceutical sciences.

[130]  Mark R Prausnitz,et al.  Transdermal delivery enhanced by magainin pore-forming peptide. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[131]  R. Tekade,et al.  Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment. , 2012, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[132]  I. Uchegbu The biodistribution of novel 200-nm palmitoyl muramic acid vesicles , 1998 .

[133]  Q. Ping,et al.  Lecithin vesicular carriers for transdermal delivery of cyclosporin A. , 2000, International journal of pharmaceutics.

[134]  N. Severs,et al.  Freeze-fracture electron microscopy , 2007, Nature Protocols.

[135]  S. Ghanbarzadeh,et al.  The effects of lyophilization on the physico-chemical stability of sirolimus liposomes. , 2013, Advanced pharmaceutical bulletin.

[136]  A. Schätzlein,et al.  Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. , 2002, Biochimica et biophysica acta.

[137]  Marcello Peppi,et al.  Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[138]  Roman Marsalek,et al.  Particle Size and Zeta Potential of ZnO , 2014 .

[139]  M. Rother,et al.  Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels. , 2008, International journal of pharmaceutics.

[140]  S. Chong,et al.  A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. , 2012, Colloids and surfaces. B, Biointerfaces.

[141]  Danhui Li,et al.  Deformable liposomes by reverse-phase evaporation method for an enhanced skin delivery of (+)-catechin , 2014, Drug development and industrial pharmacy.

[142]  G. Luo,et al.  Ligustrazine Phosphate Ethosomes for Treatment of Alzheimer’s Disease, In Vitro and in Animal Model Studies , 2012, AAPS PharmSciTech.

[143]  A. Fadda,et al.  Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. , 2011, International journal of pharmaceutics.

[144]  Kangtaek Lee,et al.  Synthesis and characterization of ethosomal contrast agents containing iodine for computed tomography (CT) imaging applications , 2014, Journal of liposome research.

[145]  K. Pathak,et al.  Therapeutic and cosmeceutical potential of ethosomes: An overview , 2010, Journal of advanced pharmaceutical technology & research.

[146]  N. Aggarwal,et al.  Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis--dermatophytosis. , 2012, International journal of pharmaceutics.

[147]  Chong-Kook Kim,et al.  Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. , 2005, Biomaterials.

[148]  F. Gao,et al.  Preparation of fluorescence ethosomes based on quantum dots and their skin scar penetration properties , 2009 .

[149]  Sanyog Jain,et al.  Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. , 2005, International journal of pharmaceutics.

[150]  A. Schätzlein,et al.  TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES , 1995 .

[151]  Sureewan Duangjit,et al.  Characterization and In Vitro Skin Permeation of Meloxicam-Loaded Liposomes versus Transfersomes , 2010, Journal of drug delivery.

[152]  B. Evrard,et al.  Skin penetration behaviour of liposomes as a function of their composition. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[153]  V. Garg,et al.  Optimization of spray drying process for formulation of solid dispersion containing polypeptide-k powder through quality by design approach , 2015 .

[154]  A. Kaur,et al.  Ethosomes-based topical delivery system of antihistaminic drug for treatment of skin allergies , 2014, Journal of microencapsulation.

[155]  K. Adler,et al.  Characterization of liposomes by scanning electron microscopy and the freeze-fracture technique , 1985 .

[156]  L. Jacob,et al.  A REVIEW ON SURFACTANTS AS EDGE ACTIVATORS IN ULTRADEFORMABLE VESICLES FOR ENHANCED SKIN DELIVERY. , 2013 .

[157]  E. Touitou,et al.  Testosterone Ethosomes for Enhanced Transdermal Delivery , 2005, Drug delivery.

[158]  H. Junginger,et al.  Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. , 1999, Biochimica et biophysica acta.

[159]  Gregor Cevc,et al.  Spatial distribution of cutaneous microvasculature and local drug clearance after drug application on the skin. , 2007, Journal of controlled release : official journal of the Controlled Release Society.